REDUCE Trial- Reducing Prolapse Recurrence
REDUCE Trial - Reducing Prolapse Recurrence by Reducing the Genital Hiatus
1 other identifier
interventional
200
1 country
1
Brief Summary
This study will examine whether surgeons should add a prophylactic posterior colpoperineorrhaphy to a mesh-augmented apical prolapse repair.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2021
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 14, 2021
CompletedFirst Posted
Study publicly available on registry
May 10, 2021
CompletedStudy Start
First participant enrolled
November 23, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 30, 2026
April 23, 2026
April 1, 2026
4.9 years
April 14, 2021
April 22, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Pelvic Organ Prolapse Quantification (POP-Q) System
The POP-Q System will be used to compare the rate of prolapse recurrence at 1 year between women undergoing a sacrocolpopexy with Restorelle mesh with and without a concomitant posterior colpoperineorrhaphy.
1 Year
Secondary Outcomes (6)
Defecatory Dysfunction
1 Year
Dyspareunia
1 Year
Surgical and Perioperative Events: Blood Loss
2 Weeks
Surgical and Perioperative Events: Operative Time
Day of surgery
Surgical and Perioperative Events: Postoperative Pain
2 Weeks
- +1 more secondary outcomes
Study Arms (2)
Sacralcolpopexy with posterior colpoperineorrhaphy
ACTIVE COMPARATORSacralcolpopexy without posterior colpoperineorrhaphy
NO INTERVENTIONInterventions
Patients having a sacralcolpopexy will be randomized to ultra lightweight mesh (Coloplast Restorelle) with posterior colpoperineorrhaphy or the same procedure without the posterior colpoperineorrhaphy
Eligibility Criteria
You may qualify if:
- Women over the age of 18
- English or Spanish speaking
- Symptomatic prolapse (stage II or greater) undergoing minimally-invasive sacrocolpopexy with Restorelle ultra lightweight mesh
- Preoperative genital hiatus with valsalva/strain greater than or equal to 4cm
You may not qualify if:
- Patient has had prior prolapse surgery
- Patient has inflammatory bowel disease (Crohn's, Ulcerative Colitis)
- Baseline dyspareunia (patient reports that they have pain with vaginal intercourse when asked as a yes/no)
- Patients with a score of 7 or greater in any one muscle on the Meister Pelvic Floor Exam
- Patient planning a concomitant Burch procedure
- Pregnant
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Northwestern University
Chicago, Illinois, 60611, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Julia Geynisman-Tan, M.D
Northwestern University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of Research; Assistant Professor
Study Record Dates
First Submitted
April 14, 2021
First Posted
May 10, 2021
Study Start
November 23, 2021
Primary Completion (Estimated)
October 1, 2026
Study Completion (Estimated)
December 30, 2026
Last Updated
April 23, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share